Arxis, Inc. Class A Common Stock

NASDAQ:ARXS

Aerospace & Defense

Industrials
$53.41 +2.20%

+$0.89 today

Market cap
$2.16B
Beta
0.00
52W Low $33.15High $48.68

Volume 0.49M

Average 1.55M

Financial health

Arxis, Inc. Class A Common Stock financial health

Start with the overall verdict and the rule-based risk checks for ARXS, then work through liquidity, debt, balance-sheet quality, and claims on cash.

Financial health snapshot

Stretched

Leverage or liquidity signals may be adding financial risk.

Debt exceeds cash and investments Healthy short-term liquidity Moderate leverage Interest cover is thin

Cash & Investments

$494.69M

Debt Cushion

-$1.29B

Current Ratio

5.2x

Interest Coverage

0.8x

Risk checks

5 of 9 flagged

  • Interest covered

    0.6×

    Passes when: Operating income is at least 1.5× interest expense

  • Manageable net debt

    4.1×

    Passes when: Net debt is below 3× EBITDA

  • Debt repayable from cash flow

    8.5 yrs

    Passes when: Free cash flow could repay all debt within 5 years

  • Tangible equity base

    117.5%

    Passes when: Goodwill and intangibles are below 50% of equity

  • Dividend funded by cash flow

    174.3% of FCF

    Passes when: Dividends paid are covered by free cash flow

  • Positive equity

    Positive

    Passes when: Shareholders' equity is above zero

  • Short-term liquidity

    5.2×

    Passes when: Current assets are at least 1× current liabilities

  • Near-term debt covered

    4157.1×

    Passes when: Cash and short-term investments cover debt due within 12 months

  • Contained stock compensation

    10.9%

    Passes when: Stock-based compensation is below 20% of operating cash flow

Financial strength scores

How strong are the fundamentals over time?

Piotroski tests profitability, balance-sheet direction, and efficiency; Altman estimates bankruptcy risk. Compare the current scores with their fiscal-year history.

Financial strength scores

Piotroski F-Score and Altman Z-Score from the latest reported financials

No financial scores available.

Score history

Piotroski F-Score and Altman Z-Score recalculated from each fiscal year's statements and year-end market value.

Liquidity

Can it meet short-term obligations?

Check whether cash and current assets cover what falls due within a year without depending on fresh financing.

Cash & Equivalents

$494.69M

Q2 2026

1Y +107.1%

Quick Ratio

3.8x

Q2 2026

Current Ratio

5.2x

Q2 2026

Cash Ratio

2.1x

Q2 2026

Working capital

How quickly does cash come back?

Receivable, inventory, and payable days show how much cash the operating cycle ties up and whether that is changing.

Working capital and cash conversion

Annual days measures from year-end receivables, inventory, and payables against revenue and cost of revenue.

Leverage

How much debt risk sits on the balance sheet?

Review total borrowings, debt relative to equity and assets, and whether operating profit covers interest costs.

Total Debt

$1.78B

Q2 2026

1Y -34.4%

Debt/Equity

0.4x

Q2 2026

Debt/Assets

0.3x

Q2 2026

Interest Coverage

0.8x

Q2 2026

Debt service

Can cash flow carry the debt?

Measure debt against EBITDA and free cash flow, see how much is due within 12 months, and follow debt and cash over time.

Debt service capacity

Can operating cash flow carry the debt, and how much is due soon?

Debt and cash over time

Fiscal-year-end borrowings against liquid assets; net debt below zero means net cash.

Balance sheet cushion

How much room is there if conditions weaken?

Extra cash and investments, and the balance of assets against liabilities, give the company room when trading gets harder.

Long-Term Investments

$0.00

Q2 2026

Assets

$7.01B

Q2 2026

1Y +5.5%

Liabilities

$2.54B

Q2 2026

1Y -26.5%

Balance sheet quality

Who funds the assets, and how tangible is the equity?

Split the claims on assets between suppliers, lenders, customers, and shareholders, and see how much equity rests on goodwill and intangibles.

Balance sheet quality

Who funds the assets, and how much of the equity is tangible (Q2 2026).

Shareholder claims

What do shareholders take out of the cash?

Dilution, stock-based pay, dividends, and buybacks all draw on cash flow; check whether free cash flow funds them.

Shareholder claims on cash

Dilution, stock-based pay, and whether free cash flow funds what is returned to shareholders.

Diluted shares, yearly change

—

Stock-based compensation

$27.26M

10.9% of operating cash flow

Dividends paid

$363.81M

FY 2025

Dividend / free cash flow

174.3%

Above 100% means dividends exceed free cash flow

Buybacks

$2.05M

FY 2025

Competitor health

How does Arxis, Inc. Class A Common Stock compare with peers?

Compare leverage, interest coverage, and liquidity ratios with similar companies.

Competitor Health

Peer financial health comparison

CompanyMarket CapD/ED/AssetsND/EBITDAInt. Cov.QuickCurrentCash

Curtiss-Wright Corporation

CW:NYSE

$17.12B0.520.251.2014.791.001.440.26

TTM Technologies, Inc.

TTMI:NASDAQ

$7.81B0.630.291.535.771.671.930.52

Karman Holdings Inc.

KRMN:NYSE

$5.39B1.530.514.621.643.173.290.38

Mercury Systems, Inc.

MRCY:NASDAQ

$4.96B0.330.212.920.711.852.960.65

Astronics Corporation

ATRO:NASDAQ

$2.13B2.700.545.436.081.713.100.13

Ducommun Incorporated

DCO:NYSE

$2.10B0.520.29Net cash5.822.473.500.25

Redwire Corp

RDW:NYSE

$1.93B0.220.16Net cash—1.271.620.61

CTS Corporation

CTS:NYSE

$1.72B0.220.160.3215.401.822.300.75

Applied Aerospace & Defense, Inc.

AADX:NYSE

$1.44B4.200.676.580.552.483.090.16

Allient Inc.

ALNT:NASDAQ

$1.32B0.670.351.981.732.083.660.59

Questions

Financial health questions

Common questions about ARXS's balance sheet, answered from the reported figures.

Is ARXS's balance sheet healthy?

Arxis, Inc. Class A Common Stock (ARXS) has a current ratio of 5.21, a quick read on short-term liquidity.

How leveraged is ARXS?

Debt to equity is 0.40, which helps judge how much financing risk sits on the balance sheet.